Fatigue Fatigue also referred to as tiredness, exhaustion, lethargy, listlessness, and describes a physical and/or mental state of being tired and weak. Signs and symptoms include aching or sore muscles, painful lymph nodes, chronic (long-term) tiredness, dizziness, headache, irritability and loss of appetite.
Fatigue pipeline therapeutics constitutes close to 6 molecules. which approximately 6 molecules are developed by Companies. The molecules developed by Companies in Pre-Registration, Phase II, IND/CTA Filed and Preclinical stages are 1, 3, 1 and 1 respectively.
Fatigue - Pipeline Review, H2 2016, outlays comprehensive information on the therapeutics under development for Fatigue, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews of key players involved in therapeutic development for Fatigue and features dormant and discontinued projects.
Key Topics Covered:
- Fatigue Overview
- Therapeutics Development
- Pipeline Products for Fatigue - Overview
- Pipeline Products for Fatigue - Comparative Analysis
- Fatigue - Therapeutics under Development by Companies
- Fatigue - Therapeutics under Investigation by Universities/Institutes
- Fatigue Products Glance
- Late Stage Products
- Clinical Stage Products
- Early Stage Products
- Fatigue - Products under Development by Companies
- Fatigue - Products under Investigation by Universities/Institutes
- Fatigue - Companies Involved in Therapeutics Development
- BioLite, Inc.
- Biovista Inc.
- Grifols, S.A.
- Hemispherx Biopharma, Inc.
- MultiCell Technologies, Inc.
For more information about this report visit http://www.researchandmarkets.com/research/7xdm4q/fatigue